Interventional oncology for hepatocellular carcinoma

Affiliation auteurs!!!! Error affiliation !!!!
TitreInterventional oncology for hepatocellular carcinoma
Type de publicationJournal Article
Year of Publication2016
AuteursDelicque J, Boulin M, Guiu B, Pelage J-P, Escal L, Schembri V, Assenat E, Fohlen A
JournalCLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
Volume40
Pagination530-537
Date PublishedNOV
Type of ArticleReview
ISSN2210-7401
Résumé

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is increasing in incidence. The overall prognosis of patients with liver cancer is poor. The Barcelona Clinic Liver Cancer (BCLC) classification in 5 stages is endorsed by European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Disease (AASLD). This classification is recommended for treatment allocation. Because a small proportion of patients are suitable for curative surgical treatment, various locoregional therapies are widely used to manage patients with HCC. The image-guided therapies, also called interventional radiology or interventional oncology (IO) techniques consisted in percutaneous or endovascular approach. This article reviews the different IO treatments available in HCC patients and the strength of the data. (C) 2016 Published by Elsevier Masson SAS.

DOI10.1016/j.clinre.2016.01.007